Lucid Diagnostics Stock (NASDAQ: LUCD) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 562.00 / 183.75K |
Day Range | - - - |
52 Wk Range | 0.63 - 1.72 |
Market Cap | $46.30M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 4.15% |
Days to Cover | 3.55 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lucid Diagnostics (NASDAQ:LUCD) through any online brokerage.
Other companies in Lucid Diagnostics’s space includes: Precision Optics Corp (NASDAQ:POCI), Pro-Dex (NASDAQ:PDEX), LENSAR (NASDAQ:LNSR), Autonomix Medical (NASDAQ:AMIX) and Modular Medical (NASDAQ:MODD).
There is no analysis for Lucid Diagnostics.
Lucid Diagnostics has a consensus price target of $5.42.
The stock price for Lucid Diagnostics (NASDAQ: LUCD) is $0.8696 last updated Today at July 22, 2024 at 8:41 AM EDT.
There are no upcoming dividends for Lucid Diagnostics.
Lucid Diagnostics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Lucid Diagnostics.
Lucid Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.